Mohsen Nabi-Afjadi (Mohsen Nabi Afjadi, Ali Azargoonjahromi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Combination Therapy

Respiratory Syndrome Coronavirus

Endoplasmic Reticulum

Top Venues

Cell communication and signaling : CCS

Medical oncology (Northwood, London, England)

Cellular & molecular biology letters

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, Fatemeh Aziziyan, Mohsen Nabi-Afjadi, Marzieh Ramezani Farani, Hamidreza Zalpoor, Maryam Azarian, Mahdiyar Iravani Saadi, Behrouz Gharesi-Fard, Evangelos Terpos, Iman Zare, Mohammad Motamedifar
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell communication and signaling : CCS 22 (1) (2024)
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, Fatemeh Aziziyan, Mohsen Nabi-Afjadi, Marzieh Ramezani Farani, Hamidreza Zalpoor, Maryam Azarian, Mahdiyar Iravani Saadi, Behrouz Gharesi-Fard, Evangelos Terpos, Iman Zare, Mohammad Motamedifar
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell communication and signaling : CCS 22 (1) (2024)
Ahmadreza Lagzian, Marziye Askari, Melika Sadat Haeri, Nastaran Sheikhi, Sara Banihashemi, Mohsen Nabi-Afjadi, Yalda Malekzadegan
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights. Medical oncology (Northwood, London, England) 41 (5) (2024)
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, Fatemeh Aziziyan, Mohsen Nabi-Afjadi, Marzieh Ramezani Farani, Hamidreza Zalpoor, Maryam Azarian, Mahdiyar Iravani Saadi, Behrouz Gharesi-Fard, Evangelos Terpos, Iman Zare, Mohammad Motamedifar
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell communication and signaling : CCS 22 (1) (2024)
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, Fatemeh Aziziyan, Mohsen Nabi-Afjadi, Marzieh Ramezani Farani, Hamidreza Zalpoor, Maryam Azarian, Mahdiyar Iravani Saadi, Behrouz Gharesi-Fard, Evangelos Terpos, Iman Zare, Mohammad Motamedifar
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell communication and signaling : CCS 22 (1) (2024)
Ahmadreza Lagzian, Marziye Askari, Melika Sadat Haeri, Nastaran Sheikhi, Sara Banihashemi, Mohsen Nabi-Afjadi, Yalda Malekzadegan
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights. Medical oncology (Northwood, London, England) 41 (5) (2024)
Ahmadreza Lagzian, Marziye Askari, Melika Sadat Haeri, Nastaran Sheikhi, Sara Banihashemi, Mohsen Nabi-Afjadi, Yalda Malekzadegan
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights. Medical oncology (Northwood, London, England) 41 (5) (2024)
Hamidreza Zalpoor, Abdullatif Akbari, Mohsen Nabi-Afjadi
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases. Human cell 35 (3) (2022)
Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Razieh Forghaniesfidvajani, Chanour Tavakol, Faranak Farahighasreaboonasr, Farid Pakizeh, Vahid Ghobadi Dana, Farhad Seif
Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases. Cellular & molecular biology letters 27 (1) (2022)
Hanieh Fahmideh, Hooriyeh Shapourian, Rasol Moltafeti, Chanour Tavakol, Razieh Forghaniesfidvajani, Hamidreza Zalpoor, Mohsen Nabi-Afjadi
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment. Oxidative medicine and cellular longevity 2022 (2022)
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, Puria Rostampour, Chanour Tavakol, Mohsen Nabi-Afjadi
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways. Inflammopharmacology 30 (5) (2022)
Mohsen Karami Fath, Ali Azargoonjahromi, Asma Soofi, Faezeh Almasi, Shahnaz Hosseinzadeh, Saeed Khalili, Kamran Sheikhi, Saeid Ferdousmakan, Soroor Owrangi, Minoovash Fahimi, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Zahra Payandeh, Navid Pourzardosht
Current understanding of epigenetics role in melanoma treatment and resistance. Cancer cell international 22 (1) (2022)
Mohsen Karami Fath, Jalil Azami, Niloofar Jaafari, Mahsa Akbari Oryani, Nafiseh Jafari, Alireza Karim Poor, Mohsen Nabi-Afjadi, Mohsen Nabi-Afjadi, Zahra Payandeh, Hamidreza Zalpoor, Dariush Shanehbandi
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. Cellular & molecular biology letters 27 (1) (2022)